MCID: PLM029
MIFTS: 48
|
Palmoplantar Keratosis
Categories:
Rare diseases, Skin diseases
|
|
MalaCards integrated aliases for Palmoplantar Keratosis:
Classifications:
ICD10:
32
|
GARD :
20
Palmoplantar keratoderma (PPK) is a group of skin conditions characterized by thickening of the skin on the palms of the hands and soles of the feet. PPK can also be a feature of various underlying syndromes. In rare forms of PPK, organs other than the skin may also be affected. PPK can be either acquired during the lifetime (more commonly) or inherited. Acquired PPKs may arise due to changes in a person's health or environment. Inherited PPKs are caused by genetic mutations that result in abnormalities of keratin, a skin protein. Depending on the genetic cause, inheritance can be autosomal dominant or autosomal recessive. Treatment is aimed at softening the thickened skin to make it less noticeable and relieve discomfort.
MalaCards based summary : Palmoplantar Keratosis, also known as palmoplantar keratoderma, is related to keratoderma, palmoplantar, with deafness and palmoplantar keratoderma, nonepidermolytic, focal 1. An important gene associated with Palmoplantar Keratosis is GJB2 (Gap Junction Protein Beta 2), and among its related pathways/superpathways are Developmental Biology and Cytoskeletal Signaling. The drug Acitretin has been mentioned in the context of this disorder. Affiliated tissues include skin, tongue and eye, and related phenotypes are Decreased viability and Decreased viability Disease Ontology : 12 A keratosis characterized by abnormal thickening of the palms and the soles. KEGG : 36 Palmoplantar keratodermas (PPK) comprise a heterogeneous group of keratinization disorders with hyperkeratotic thickening of palms and soles. Sporadic or acquired forms of PPKs and hereditary forms exist. The causes of acquired PPK vary, and include exposure to certain chemicals, side effects of certain drugs, and metabolic disorders. There is as yet no cure for hereditary PPK. In patients with acquired PPK, the cause should be treated or eliminated, if possible. In both instances, optimized treatment can lead to a significant improvement in symptoms. Topical therapy with urea-based ointments improves the skin's absorption of moisture and has keratolytic effects. Topical vitamin D therapy is another option. Wikipedia : 74 Palmoplantar keratodermas are a heterogeneous group of disorders characterized by abnormal thickening of... more... |
GenomeRNAi Phenotypes related to Palmoplantar Keratosis according to GeneCards Suite gene sharing:26
MGI Mouse Phenotypes related to Palmoplantar Keratosis:46
|
Drugs for Palmoplantar Keratosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
Interventional clinical trials:
|
Genetic tests related to Palmoplantar Keratosis:
|
MalaCards organs/tissues related to Palmoplantar Keratosis:40
Skin,
Tongue,
Eye,
Colon,
Prostate,
Neutrophil
|
Articles related to Palmoplantar Keratosis:(show top 50) (show all 1219)
|
ClinVar genetic disease variations for Palmoplantar Keratosis:6
|
Search
GEO
for disease gene expression data for Palmoplantar Keratosis.
|
Pathways related to Palmoplantar Keratosis according to GeneCards Suite gene sharing:(show all 12)
|
Cellular components related to Palmoplantar Keratosis according to GeneCards Suite gene sharing:(show all 13)
Biological processes related to Palmoplantar Keratosis according to GeneCards Suite gene sharing:(show all 20)
Molecular functions related to Palmoplantar Keratosis according to GeneCards Suite gene sharing:
|
|